Microbiological characteristics and susceptibility patterns of strains of Rhodotorula isolated from clinical samples

Mycopathologia

Volumn 145, Issue 3, 1999, Pages 109-112

  Galán Sánchez, Fátima ^a,b   García Martos, Pedro ^a   Rodríguez Ramos, Claudio ^a   Marín Casanova, Pilar ^a   Mira Gutiérrez, Jose ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^b NONE   (Spain)

Author keywords

Antifungal agents; Rhodotorula; Susceptibility patterns

Indexed keywords

ANTIFUNGAL AGENT;

ARTICLE; DRUG EFFECT; FECES; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MYCOSIS; NAIL; RHODOTORULA; SKIN;

ANTIFUNGAL AGENTS; FECES; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOSES; NAILS; RHODOTORULA; SKIN;

EID: 0342723785     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007059005753     Document Type: Article

References (29)

1. Pérez-Ramos S, Mira Gutiérrez J. Contribución al estudio del género Rhodotorula. Rev San Hig Pub 1983; 57: 493-499.
2. Kiehn E, Gorey E, Brown AE, Edwards FF, Armstrong D. Sepsis due to Rhodotorula related to use of indwelling central venous catheters. Clin Infect Dis 1992; 14: 841-846.
3. Walsh TJ, González C, Roilides E, Mueller BU, Ali N, Lewis LL, Whitcomb TO, Marshall DJ, Pizzo PA. Fungemia in children infected with the human immunodeficiency virus: new epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy. Clin Infect Dis 1995; 20: 900-906.
4. Goldani LZ, Craven DE, Sugar AM. Central venous catheter infection with Rhodotorula minuta in a patient with AIDS taking suppressive doses of fluconazol. J Med Vet Mycol 1995; 33: 267-270.
5. Jiménez-Mejías ME, Ortiz C, Jiménez-Gonzalo FJ, del Nozal M, Campos T, Jiménez FJ. Funguemia por Rhodotorula mucilaginosa en relación con nutrición parenteral total. Enferm Infec Microbiol Clin 1992; 10: 543-546.
6. Leeber DA, Cher I.Rhodotorula fungemia presenting as 'endotoxic' shock. Arch Intern Med 1969; 123: 78-81.
7. Pien FD, Thompson RL, Deye D, Roberts GD. Rhodotorula septicemia: two cases and review of the literature. Mayo Clinic 1980; 55: 258-260.
8. Rusthoven JJ, Feld R, Tuffuell PJ. Systemic infection by Rhodotorula spp. in the immunocompromised host. J Infect 1984; 8: 241-246.
9. Muralidhar S, Sulthana CM. Rhodotorula causing chronic dacryocystitis: a case report. Indian J Ophthalmol 1995; 43: 196-198.
10. Gregory JK, Haller JA. Chronic postoperative Rhodotorula endophtalmitis. Arch Ophthalmol 1992; 110: 1686-1687.
11. Guerra R, Cavallini GM, Longanesi L, Casolari C, Bertoli G, Rivasi F, Fabio U. Rhodotorula glutinis keratitis. Int Ophthalmol 1992; 16: 187-190.
12. Penninigton JC, III, Hauer K, Miller W. Rhodotorula rubra peritonitis in an HIV + patient on CAPD. Del Med J 1995; 67: 184.
13. Eisenberg ES, Alpert BE, Weiss RA, Mittman N, Soeiro R. Rhodotorula rubra peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Am J Med 1983; 75: 349-352.
14. Wrong V, Ross L, Opas L, Lieberman E. Rhodotorula rubra peritonitis in a child undergoing intermittent cycling peritoneal dialysis. J Infect Dis 1988; 157: 393-394.
15. Young C, Chang MH, Chen JM. Fungal esophagitis in children. Acta Paediatr Sin 1993; 34: 436-442.
16. Louria DB, Blevins A, Armstrong D, Burdick R, Liberman P. Funguemia caused by 'non pathogenic' yeast. Arch Intern Med 1967; 119: 247-252.
17. Naveh Y, Friedman A, Merzbach D, Hashman N. Endocarditis caused by Rhodotorula successfully treated with 5-fluorocytosine. Br Heart J 1975; 37: 100-104.
18. Riopedre RB, de Cesare I, Miatello E, Caria MA, Zapater RC. Aislamiento de Rhodotorula mucilaginosa del L.C.R., heces, orina, exudado faríngeo y piel de un lactante de 3 meses. Rev Asoc Med Argent 1960; 74: 431-434.
19. Pore RS, Chen J. Meningitis caused by Rhodotorula. Sabouradia 1976; 14: 331-335.
20. Kennedy M. Pseudoepidemic of Rhodotorula rubra in patients undergoing fiberoptic bronchoscopy. Infect Control Hosp Epidemiol 1990; 11:334.
21. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard M-27A. National Committee for Clinical Laboratory Standars, Villanova, PA, USA, 1997, Vol. 17, No. 9.
22. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE program. Diagn Microbiol Infect Dis 1998; 31: 327-332.
23. Espinel-Ingroff A, Pfaller M, Messer SA, Knapp CC, Killian S, Norris HA, Ghannoum MA. Multicenter comparison of the sensititre Yeast. One Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory Standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms. J Clin Microbiol 1999; 37: 591-595.
24. Rose HD, Kurup VP. Colonization of hospitalized patients with yeastlike organism. Sabouradia 1977; 15: 251-256.
25. Nuutinen J, Kunnas K, Sepp J, Karj J, Kolonen S. The mycotic flora of adenoides and antibodies to Candida albicans in children. Arch Otorhinolaryngol 1986; 243: 194-196.
26. Coppola S, Angarano G, Montagna MT. Efficacy of itraconazole in treating AIDS-associated infections due to Candida krusei. Eur J Epidemiol 1995; 11: 243-244.
27. Hazen KC. New and emerging yeast pathogens. Clin Microbiol Rev 1995; 8: 462-478.
28. Marinova I, Szabadosová V, Brandeburová O, Krcméry V. Rhodotorula spp. fungemia in an immunocompromisd boy after neurourgery successfully treated with miconazole and 5-flucytosine: case report and review of the literature. Chemotherapy 1994; 40: 287-289.
29. Hussain Qadri SM, Fluornoy DJ, Qadri SG, Ramirez EG. Susceptibility of clinical isolates of yeasts to antifungal agents. Mycopathologia 1986; 95: 183-187.